
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update
00:00
Challenges of managing TP 53 mutated disease with complex cytogenetics in AML
Discussion on the challenges faced by community oncologists in managing TP 53 mutated disease with complex cytogenetics in a patient with AML, including the potential use of a drug called McGrolla map and its effects on red blood cells.
Transcript
Play full episode